Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.48%
1,088.00
+5.20
+0.48%
1,082.801,079.311,090.181,079.31
SIXC
Communications
SIXC
Communications
SIXC
+0.54%
607.06
+3.29
+0.54%
603.77603.77611.65602.09
SIXE
Energy
SIXE
Energy
SIXE
-0.84%
1,200.97
-10.22
-0.84%
1,211.191,203.051,203.481,182.72
SIXI
Industrials
SIXI
Industrials
SIXI
+0.28%
1,760.84
+4.85
+0.28%
1,755.991,759.061,761.041,747.23
SIXM
Financials
SIXM
Financials
SIXM
-0.82%
633.30
-5.21
-0.82%
638.51637.93640.10631.89
SIXR
Staples
SIXR
Staples
SIXR
+1.34%
854.24
+11.28
+1.34%
842.96843.54858.44843.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.07%
219.43
+0.15
+0.07%
219.28219.28220.58218.64
SIXT
Technology
SIXT
Technology
SIXT
-0.75%
3,700.36
-27.99
-0.75%
3,728.353,745.063,745.063,675.02
SIXU
Utilities
SIXU
Utilities
SIXU
-0.50%
910.93
-4.55
-0.50%
915.48914.49915.84907.90
SIXV
Health care
SIXV
Health care
SIXV
+0.26%
1,501.25
+3.89
+0.26%
1,497.361,500.651,514.701,495.89
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.61%
2,452.02
+38.85
+1.61%
2,413.172,431.692,463.522,431.69
PYXS:NASDAQ
Pyxis Oncology Inc
$1.78
+8.90%
(+0.14) 1D
May 27, 2:00:32 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PYXS...
Open
$1.60
High
$1.78
Low
$1.60
Mkt. cap
111.51M
Avg. vol.
617.72K
Volume
300.26K
52-wk high
$5.55
52-wk low
$0.97
EPS
-$1.30
Beta
1.43
Shares outstanding
63.36M
No. of employees
56
News stories
From sources across the web
About Pyxis Oncology Inc
CEO-
Employees56
Founded2018
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.37 / -$0.35
-4.72%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.82M
-
11.04M
-
Cost of goods sold
-
-
2.39M
-
Cost of revenue
-
-
2.39M
-
Research and development expenses
17.13M
17.81M
21.71M
19.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.75M
4.97M
4.54M
3.75M
Operating expense
21.89M
22.78M
26.25M
23.73M
Total operating expenses
21.89M
22.78M
28.64M
23.73M
Operating income
-19.07M
-22.78M
-17.60M
-23.73M
Other non operating income
-
-
-
-
EBT including unusual items
-18.07M
-22.00M
-17.00M
-23.27M
EBT excluding unusual items
-18.07M
-22.00M
-17.00M
-23.27M
Income tax expense
283.00K
-
1.10M
-
Effective tax rate
-1.57%
-
-6.49%
-
Other operating expenses
-
-
-
-
Net income
-18.35M
-22.00M
-18.11M
-23.27M
Net profit margin
-650.85%
-
-164.03%
-
Earnings per share
-0.30
-0.35
-0.29
-0.37
Interest and investment income
995.00K
774.00K
600.00K
457.00K
Interest expense
-
-
-
-
Net interest expenses
995.00K
774.00K
600.00K
457.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.53M
-22.25M
-14.71M
-22.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more